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CLINICAL MEDICINE AND THE FUTUREt
The only certainty about the future of clinical medicine is that it will
constantly be undergoing change. On the one hand it responds to the ever-
expanding body of clinical knowledge, and on the other to the varying
political and economic situations of the world. I shall be concentrating today
onour increasing understanding of medical phenomena; nevertheless, simply
to illustrate the influence of economic factors let me remind you of the kinds
of medical problems that present themselves in different parts of the world
today. There are places where the average span of life is short, and where
the principal health problems are caused by inadequate food or infectious
diseases such as typhoid fever. By contrast, in a large Western city some of
the major medical problems are provided by automobile accidents, air
pollution, obesity, alcoholism, hypertension, and the disorders of old age.
Clearly then, clinical medicine is bound to be influenced by the changing
economic, technical, political and social developments of this turbulent
world; most of these are quite beyond the influence of members of the
medical profession.
Now to take up the aspect of the future that we can influence. Let me
first describe the methods by which our existing body of clinical knowledge
has been obtained. I believe it fair to say that there was little understanding
of the mechanisms of disease prior to the beginning of the last century.
Then, stimulated by the example of clinicians like Richard Bright, men
began to correlate the manifestations of illness with pathologic changes in
different organs. This simple method of observation has been responsible for
the accumulation of a large mass of factual information about disease.
The next step was the application of laboratory methods. First came the
niew science of bacteriology, almost immediately adapted to clinical medi-
cine; then physicians began to realize that additional help could be gained
from the techniques and knowledge of chemists and physiologists. At the end
of the century the discovery of X-ray found clinicians everywhere ready to
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take immediate advantage of a new means of elucidating the phenomena of
illness.
Along with growing understanding of pathologic processes came some
improvements in therapy, usually it must be confessed, as a result of chance
observation. The most notable of these of course was surgical anesthesia,
which permitted operations to be performed deliberately and to be under-
taken on an elective basis. This was the major factor enabling surgery to
develop into the wonderfully skillful thing it is today.
So by the end of the last century our main methods for study of clinical
medicine had been worked out. We of the twentieth century can point only
to certain modifications and improvements. For example we have fostered
the development of a new kind of scientist: the clinical investigator. Previ-
ously all studies of clinical medicine had been carried out merely when
convenient, and incidental to the demands of private practice. Now, paid by
salaries and usually specially trained in basic medical sciences, clinical
investigators are in a favorable position to learn about disease.
Another contribution of the present century is a great expansion in the
total effort of medical research. This came about as a result of changing
political and economic circumstances. During the Second World War
came the demonstration that by massive expenditure of funds and man-
power certain specified scientific goals could be achieved; examples are
the atomic bomb, radar, and the manufacture of penicillin. From this
experience the inference was drawn that disease problems likewise could be
solved by spending large sums of money on medical research. Federal
agencies and private foundations, especially in our own country, began in
the late 1940's to provide support on a scale previously unknown. Industry,
too, began to invest in medical research, on finding that the development
and sale of drugs such as antibiotics, steroid compounds, and tranquilizers
could be very profitable.
Thus we have seen within the past few years an unprecedented infusion
of manpower and funds into clinical investigation, and into related scientific
fields. The result has been a series of changes in clinical practice so remark-
able as to be difficult to appreciate, even by those of us who have been
active participants. To emphasize this I propose to spend a few minutes in
a review of some of the high points within my own professional experience.
Let us imagine a Dr. Rip Van Winkle, who has just awakened after a
twenty-year sleep, and sets out to visit a teaching hospital. He would find
many more doctors workingthere, and would observe also that the buildings
have been enlarged, not to accommodate more patients, but to house
laboratories and special treatment facilities. He would be unfamiliar with
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the institution known as the Blood Bank, and would be amazed to learn
that the hospital now has devices which can substitute temporarily for the
human kidney or heart or lung.
In the operating rooms he would observe impressive developments in
anesthesia, and would learn that hypothermia or hypotension are now some-
times deliberately induced during major operative procedures. Some of the
surgery he would hardly have thought possible: for example, reconstructive
procedures within the chambers of the heart. He would be surprised to
find that long confinement in bed after major surgery has been abandoned,
and that patients now often stand or take a few steps on the first postopera-
tive day.
In the medical wards of the hospital the visitor would find that the aver-
age age of patients is about 20 years greater than in 1940, due principally
to new treatments for infectious disease. He would be delighted to find
that certain serious infections like bacterial meningitis or endocarditis,
which he had regarded as usually fatal, are now looked upon as curable.
One of the most impressive changes would be virtually new pharma-
copoeia. Of the drugs which were in common use in 1940 the principal
survivors today are morphine, the barbiturates and aspirin. Even digitalis
appears in new purified forms. The antibiotics and steroid compounds,
both unknown to clinicians in 1940, now account for the majority of all
prescriptions. Other impressive innovations include diuretics, so effective
that the clinical picture of dropsy has become comparatively rare, and drugs
which can, temporarily at least, retard the progress of some kinds of cancer.
In the realm of diagnostic procedures the visitor would doubtless be
appalled by the increased number and complexity of tests. Whereas in
1940 a basal metabolic rate determination seemed about the ultimate in
physiological measurement, cardiac catheterization has now become com-
monplace. In the X-ray department he would find pieces of equipment
being used for unfamiliar examinations such as cinefluorography. In the
chemistry laboratories it would be apparent that clinicians now consider
essential many determinations he never used, such as measurement of blood
sodium and potassium. The chemical equipment itself would be mystify-
ing, with its electronic systems of measurements, and techniques like
electrophoresis.
So much for Dr. Rip Van Winkle. I felt it worth while to devote some
of this discussion to the past because I believe that only by considering the
circumstances that have brought us to our present position can we hope to
make reasonable guesses about the future. I emphasized the great changes
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we have witnessed recently to show the ferment of activity that is in clinical
medicine today. We can expect this state to continue-indeed probably
even to be magnified-so that medical practice in the forseeable future is
likely to change almost beyond recognition every generation or so.
Now what is our long-range goal in medical research? It is to obtain
knowledge that will enable us to define accurately the various factors and
events that lead to the development of different kinds of disease. With
that kind of information we can hope to devise effective means of preven-
tion or treatment.
Short of the goal of complete understanding and rational treatment, we
may, of course, be able to alleviate the manifestations of disease, as for
example, when we use a steroid compound to suppress an intense allergic
reaction. In this phase of practice we can anticipate a series of discoveries
which will have practical value. One of the major obligations of clinical
investigators is going to be the careful appraisal of new compounds, so
that their full range of effects on human beings can be determined as
quickly and safely as possible. The pharmaceutical industry will direct to
us a steady flow of new antimicrobial preparations, steroid hormones and
drugs affecting mood, consciousness or pain sensation, as well as drugs to
raise or lower blood pressure, or to influence the excretion of salt and
water.
What lies ahead for surgery? At present it seems that most surgical
procedures can be placed in either of two categories: repair of injury,
or removal of diseased tissue. Repair of injury is presently being
exploited with considerable success in the field of cardiovascular disease.
We can anticipate great technical advances in open heart surgery, and in
replacement of diseased arteries by plastic tubes. We can hope that better
procedures will be devised for improving the circulation of the heart itself.
In respect to surgery for removal of diseased tissue, it seems to me we
cannot look forward to greatly improved results. Of course there will be
technical advances, and, without doubt, this kind of treatment will be the
best available for a long time to come. Nothing now in sight promises to
substitute for removal of an inflamed appendix, or an enlarged prostate,
or a cancerous bowel. But our hope should be to make that kind of treat-
ment obsolete. It has already been accomplished to some extent in mas-
toiditis and hyperthyroidism.
There is in sight the prospect of a great new field for surgery. Instead
of plucking out the diseased part the surgeon will substitute for it a healthy
tissue. This has actually been achieved already, under special circum-
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stances, in that a normal human kidney has been transplanted successfully
into the body of a person with severe renal disease. The obstacle to be
overcome before this can be employed on a wide scale is the curious allergy
exhibited by each of us to acceptance of a graft from any other person.
This immunological reaction usually results in rejection of the transplanted
tissue within a few days. The phenomenon is under intensive study by
immunologists all over the world. Only last week the Nobel Prize in
Medicine was awarded to two scientists who are working in the field. I
am confident that a solution will be found, so that the transplanting of
tissues and organs from healthy to diseased persons will be a practical
method of treatment within the next decade or two. When that happens
the possible applications are almost limitless.
Among medical diseases one might predict that substantial progress is
to be made soon in some genetic diseases, the so-called inborn errors in
metabolism. Real advances have been achieved within the past decade by
workers in the fields of microbial genetics and nucleic acid chemistry.
Clinicians have begun to develop better techniques for study of genetic dis-
orders in man. There is every indication that some of these conditions are
caused by simple and identifiable biochemical defects perhaps involving
single enzyme systems. Detailed knowledge of these should lead to effective
treatment, perhaps merely the administration of some substance the patient
cannot make himself. This would be comparable with the cure of a defi-
ciency disease by giving the appropriate vitamin.
Arteriosclerosis becomes relatively more and more important in human
disease, because of the steadily lengthening span of life. Much work has
been done on this problem, both in man and in animals. Of the possible
causative factors, diet, endocrine function, blood pressure, race and environ-
ment have received special attention. Their relative importance is being
disputed at present; nevertheless some progress is being made. That diet
seems to play a role gives us reason to believe that preventive and even
curative treatment are not beyond possibility. What we must have is better
understanding of the events leading to deposit of fatty substances in arterial
walls.
There is reason forhope also in connection with another important cardio-
vascular disease: hypertension. Here, too, we deal with a disorder of
complex and variable etiology, but it is susceptible to study in animals and
in man. Information about its humoral and neural mechanisms is growing.
Even now we have drugs of some value in management of the most serious
forms of hypertension. The eventual prospect for control of the disorder
is good.
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What about the outlook in the cancer problem? Here we have a diverse
group of diseases, where multiple factors seem to be involved: heredity,
endocrine function, chronic irritation, virus infection, and possibly immune
mechanisms. The role of these, and doubtless other factors, needs to be
defined far more clearly than at present. Experiments in animals are of
value, but the findings are difficult to interpret in terms of human disease.
Our present methods of treatment, surgery and radiation, while curative
in some situations are worthless in others; and I see little prospect that
these methods can be made a great deal more effective. We all hope that
some kind of chemical approach to treatment will eventually be developed,
and indeed this is an active field of investigation. Much of the work, how-
ever, is nothing more than blind trial-and-error; at best it is based on what
might be called educated guesses. Here and there encouraging results have
been obtained, but I fear we must expect neoplastic disease to be an impor-
tant cause of death for a long time to come.
I turn now to the problem of mental disorders. Neuroses and psychoses
certainly account for a large share of all suffering and disability. Con-
sidering their great importance one may wonder why so little research is
being done in the field. An obvious explanation is the problem of finding
something with which to work. Animal experiments have severe limitations,
there is no recognizable pathology to correlate with symptoms, and labora-
tory tests have thus far yielded nothing significant. Faced with this situation
the psychiatrist must do what he can on the basis of clinical observation
alone. When we stop to consider that mental disorders are likely to be the
product of such intangibles as heredity and the individual's total life ex-
perience, we can appreciate the vast difficulties that must be met in com-
prehending psychiatric illness. Quite understandably the field at present
is characterized by disagreement. To be sure, in the matter of treatment
some progress has been made, but the methods are so cumbersome and
expensive that they scarcely affect the total problem of psychiatric illness.
Some of the recently introduced drugs which affect mood and behavior
have eased difficulties in patient management, and we can expect further
progress in that direction. But in terms of the goal of understanding-in-
depth psychiatry seems to represent a far more difficult problem than we
have in many other branches of clinical medicine.
The last subject I shall mention specifically is that of aging. Here I
believe we must be willing to expect defeat. There is little reason to hope
we shall ever see exceptions to the general law that all living things eventu-
ally deteriorate and die. Neuropathologists tell us there is a net decrease
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in number of nerve cells in the brain every day of our lives after the third
decade. Other parts of the body must also suffer steady impairment, simply
from the ordinary buffetings of living. Although I have just been predicting
the discoveryof methods to combat coronary artery disease andhypertension
there remains the probability that one day, the heart, after beating 70 times
a minute during a long life, will just wear out.
So much for guessing about the future. I have been seeking to picture a
sort of spectrum among the major disease problems. At one end are those
where causative mechanisms can be identified, where good tools for study
are available, and the prospects for control seem relatively good. At the
other end are those which develop insidiously, probably because of multiple
inter-acting forces. These are generally difficult to study, and progress
seems likely to be slow in coming.
The 150-year span of time that we celebrate today has seen important
changes in the picture of human disease. A crude understanding of causa-
tive mechanisms has been gained, and some effective forms of medical and
surgical treatment have been developed. In a few areas, notably the in-
fectious diseases, endocrine disorders and nutritional deficiency diseases,
we are able to speak in terms of curative treatment.
Just how far have we come in 150 years? In particular, how will those
who follow us look back upon the present period? Despite its activity, I
think this will not be regarded as a Golden Era in medical science. Its most
notable aspect is simply the stepped-up tempo of scientific investigation.
We must not exaggerate the extent of our achievements merely because
they have created such changes in the appearance of clinical medicine. Al-
though we're glad we can relieve headache by prescribing aspirin we should
not be satisfied until we know why it is that people with many different
kinds of disturbance feel pain in the head. Unfortunately, most of our
treatment is still in the aspirin-for-headache category. I pointed out earlier
that dropsy is uncommon now because the diuretic agents we use are so
effective, yet this is purely symptomatic treatment which has no effect on
the basic disease of heart or liver that caused the retention of water. Con-
sider how ignorant we are even where we have chanced upon a curative
treatment, as with penicillin in pneumonia. We have little understanding
of the ways in which bacterial infection of the lung produces its manifesta-
tions, and we have failed so far even to answer the simple question how
penicillin interferes with bacterial growth.
We are therefore only in the early phases of a long search. With better
understanding, prevention and cure of many important diseases will be
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possible. Yet we must accept too that complete success can never be
achieved. Better treatment for some diseases will increase the relative seri-
ousness of the unsolved problems. Changing conditions in the universe will
unquestionably bring out new medical challenges. I suppose we might look
upon successive medical generations as riders in a never-ending Pony Ex-
press, none of them being privileged to reach the destination. This, how-
ever, does not seem to me a discouraging prospect. We can be confident
that we are travelling in the right direction, with an overall result of steady
improvement in the alleviation of suffering. It is satisfaction enough for
any of us to participate in this combined effort, and to share the pleasure
when anyone, anywhere, provides us with a little more understanding.
Additional Issues Available
Single copies of this issue may be ordered from the Journal office
at the price of $2.50 per copy.
Yale Journal of Biology and Medicine
333 Cedar Street
New Haven 11, Connecticut
242